Larry Michael Mertz - 22 May 2023 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role: Chief Technology Officer
Signature: /s/ David Patience, attorney-in-fact
Issuer symbol: AXDX
Transactions as of: 22 May 2023
Net transactions value: -$2,506
Form type: 4
Filing time: 24 May 2023, 20:03:31 UTC
Previous filing: 06 Mar 2023
Next filing: 20 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXDX	Common Stock	Options Exercise	$0	+10,000	+1.9%	$0.000000	526,339	22 May 2023	Direct	F1
transaction	AXDX	Common Stock	Sale	$1,952	-2,711	-0.52%	$0.7200	523,628	22 May 2023	Direct	F2
transaction	AXDX	Common Stock	Options Exercise	$0	+2,836	+0.54%	$0.000000	526,464	22 May 2023	Direct	F3
transaction	AXDX	Common Stock	Sale	$554	-769	-0.15%	$0.7200	525,695	22 May 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXDX	Employee Restricted Stock Units	Options Exercise	$0	-10,000	-50%	$0.000000	10,000	22 May 2023	Common Stock	10,000		Direct	F1
transaction	AXDX	Employee Restricted Stock Units	Options Exercise	$0	-2,836	-50%	$0.000000	2,835	22 May 2023	Common Stock	2,836		Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 30,000 restricted stock units, which vests in equal amounts every year over three years, which started vesting on May 20, 2022.
F2	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F3	The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 8,507 restricted stock units, which vests in equal amounts every year over three years, which started vesting on May 20, 2022.